Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(211 intermediate revisions by 11 users not shown)
Line 1: Line 1:
Welcome! 


*We are creating content for all entities with genetic findings in the current WHO Classification of Tumours books.
*Please select a link in the table to your book(s) of interest.  Additional books are in the process of being added.
*To volunteer, please '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your page of interest.
<br />
{| class="wikitable"
{| class="wikitable"
|+BOOKS WITH CONTENT IN PROGRESS
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
!Book Name
!Book Edition
!Book Acronym
|-
|-
|[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]]
!'''Disease'''!!'''Page Type'''!!'''Author'''
|5th
|HAEM5
|-
|[[CNS5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Central Nervous System]]
|5th
|CNS5
|-
|[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]]
|5th
|GTS5
|-
|[[BRST5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Breast]]
|5th
|BRST5
|-
|[[STBT5:Volunteer Assignments and Opportunities|WHO Classification of Soft Tissue and Bone Tumours]]
|5th
|STBT5
|}
 
{| class="wikitable"
|+BOOKS COMING SOON
!Book Name
!Book Edition
!Book Acronym
|-
|[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]]
|5th
|EYE5
|-
|[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]]
|5th
|SKIN5
|-
|[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]]
|5th
|HAN5
|-
|[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]]
|5th
|ENDO5
|-
|[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]]
|5th
|MALE5
|-
|[[PEDS5:Volunteer Assignments and Opportunities|WHO Classification of Paediatric Tumours]]
|5th
|PEDS5
|-
|[[THOR5:Volunteer Assignments and Opportunities|WHO Classification of Thoracic Tumours]]
|5th
|THOR5
|-
|[[FEMA5:Volunteer Assignments and Opportunities|WHO Classification of Female Genital Tumours]]
|5th
|FEMA5
|-
|[[DIG5:Volunteer Assignments and Opportunities|WHO Classification of Digestive System Tumours]]
|5th
|DIG5
|}
 
<br />
__TOC__
 
==WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Target Completion Date'''
Line 96: Line 17:
|
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|Date page was created
|
|
|
|-
|-
Line 106: Line 27:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 116: Line 37:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 140: Line 61:
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|
|
|complete
|complete/pending faculty review
|
|
|FQR
|FQR
Line 150: Line 71:
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Chelsea D. Kramish (trainee), Daynna J.Wolff
|(trainee), Daynna J.Wolff
|
|
|
|
|complete/pending faculty review
|pending faculty review
|
|
|FQR
|FQR
Line 161: Line 82:
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|Thomas Lee
|
|8/17/2020
|
|9/7/2020
|complete
|complete
|
|
Line 169: Line 90:
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''||Shashi Shetty, Ph.D.
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|
|
Line 178: Line 99:
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung + Shuo-Shawn Liu (trainee)
|Thuy Phung/Shuo-Shawn Liu
|
|
|
|
|complete
|complete/pending adding content online as of 2/4/21
|
|
|FQR
|FQR
Line 198: Line 119:
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung +Jordan Lowery (trainee)
|Thuy Phung +Jordan Lowery
|
|
|
|
Line 254: Line 175:
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|
|
Line 265: Line 186:
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|
|
Line 304: Line 225:
|
|
|9/1/20
|9/1/20
|PENDING importing content and reference formatting
|PENDING
|
|
|FQR
|FQR
|
|
|FQR has emailed SR several times, last 4/20/22
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
Line 316: Line 237:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 328: Line 249:
|
|
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Jack Reid (trainee)+Fabiola Quintero-Rivera
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|
|4/21/22
|9/1/20
|pending
|pending
|
|
Line 366: Line 287:
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 376: Line 297:
|
|
|9/1/20
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 403: Line 324:
|
|
|9/1/20
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 409: Line 330:
|
|
|-
|-
|Myelodysplastic Neoplasm with Biallelic TP53 Inactivation
| || ||
|Disease
|
|Eric McGinnis
|
|
| ||
|
|
|5/4/23
|PENDING
| ||FQR
|
|
|'''Page New in 5th Edition of Book'''. 2021 template added.
|-
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
Line 439: Line 358:
|
|
|
|
|''<s>PENDING</s> Complete - awaiting clarification''
|PENDING
| ||JH / MS
| ||JH / MS
|04/26/2021 -MS (re-review)
|04/26/2021 -MS (re-review)
|Review completed, awaiting some clarification from JH - 07/04/2022
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
Line 549: Line 468:
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
Corboy (Monash Health)
|
|
|
|
Line 558: Line 476:
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
Line 566: Line 484:
|Add WHO reference
|Add WHO reference
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Corboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|
|
Line 784: Line 702:
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Disease
|Kay Weng Choy + Greg Corboy (Monash Health)
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
Line 827: Line 745:
|
|
|
|
| ||Holli Drendel (HD)
| ||Yassmine Akkari (YA)
|
|
|
|YA (prior AE)
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
Line 835: Line 753:
|
|
|
|
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain (trainee) + Yassmine Akkari
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
Line 852: Line 770:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
Line 860: Line 778:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
Line 868: Line 786:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
Line 879: Line 797:
|Complete
|Complete
|
|
|HD
|YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
Line 887: Line 805:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
Line 895: Line 813:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
Line 904: Line 822:
|Complete
|Complete
|
|
|HD
|YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|
|
|
|
|Complete
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
Line 920: Line 838:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
Line 931: Line 849:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
Line 942: Line 860:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
Line 953: Line 871:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
Line 964: Line 882:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
Line 975: Line 893:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
Line 986: Line 904:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
Line 994: Line 912:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
Line 1,002: Line 920:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE); 2021 template added
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
Line 1,010: Line 928:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE); 2021 template added
|-
|-
| || ||
| || ||
Line 1,026: Line 944:
|
|
|
|
| ||Shivani Golem (SG)
| ||Snehal Patel (SP)
|
|
|
|SP (prior AE)
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Jaime Nagy, PhD/
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
 
|
Renee Eigsti, MD
|
|
|
|
|
|PENDING
|SP
|
|
|SG
|
|
|SP (prior AE); NOTE TO BAILEY: author updating page on staging server with conversion to new template (small amount of content on older template with 4th edition content - need to convert to new template and update to 5th edition content). Then transfer to production server when ready.
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Tsigab Bahta Hagos (trainee) / Shashirekha Shetty
|       Monoclonal B-cell  Lymphocytosis||Disease||
|12/19/2022
|
|1/19/2023
|
|PENDING
|
|
|SP
|
|
|SG
|
|
|SP (prior AE), 2021 template added
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||NOT NEEDED. DO NOT ASSIGN
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|
|
|
|
|SP
|
|
|
|
|SP (prior AE); 2021 template added; No longer an entity
|-
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
Line 1,064: Line 980:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|Hairy Cell Leukemia||Disease||Snehal Patel
Line 1,073: Line 989:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
Line 1,082: Line 998:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
Line 1,091: Line 1,007:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
Line 1,100: Line 1,016:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|
|Complete
|
|
|SG
|SP
|4/12/2023 by FQR
|
|SP (prior AE); 2021 template added
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
|   Waldenstrom  Macroglobulinemia||Disease||
|
|
|
|
|
|SP
|
|
|Complete
|
|
|SG
|4/12/2023 by FQR
|SP (prior AE); 2021 template added
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
Line 1,126: Line 1,042:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
Line 1,134: Line 1,050:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|    Mu Heavy Chain  Disease||Disease||
|    Mu Heavy Chain  Disease||Disease||
Line 1,142: Line 1,058:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
Line 1,150: Line 1,066:
|
|
|Complete
|Complete
|5/26/2021||SG
|5/26/2021||SP
|
|
|
|SP (prior AE)
|-
|-
|    Alpha Heavy Chain  Disease||Disease||
|    Alpha Heavy Chain  Disease||Disease||
Line 1,158: Line 1,074:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
Line 1,167: Line 1,083:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
Line 1,176: Line 1,092:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
Line 1,185: Line 1,101:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
Line 1,194: Line 1,110:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Plasmacytoma||Disease||Zhenya Tang
|    Plasmacytoma||Disease||Zhenya Tang
Line 1,203: Line 1,119:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||Chen Yang, MD, PhD
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|
|Complete
|09/10/2022||SG
|
|
|SP (prior AE)
| ||SP
|
|
|-
|-
|           Primary  Amyloidosis||Disease||Heather E. Williams, PhD
|           Primary  Amyloidosis||Disease||
|
|
|
|
| ||SP
|
|
|?PENDING
| ||SG
|
|
|SP (prior AE)
|-
|-
|           Light Chain and Heavy Chain Deposition Disease||Disease||Chen Yang, MD, PhD
|           Light Chain and Heavy Chain Deposition Disease||Disease||
|
|
|
|
| ||SP
|
|
|Complete
|10/15/2022||SG
|
|
|SP (prior AE)
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||Sohini Anand
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|8/31/2021
|
|9/15/2021
|
|PENDING
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|         POEMS Syndrome||Disease||Sohini Anand, MBBS, and Tharanga Niroshini Senaratne, PhD
|         POEMS Syndrome||Disease||
|
|
|
|
|?PENDING
| ||SG
|
|
|SP (prior AE)
| ||SP
|
|
|-
|-
|         TEMPI Syndrome||Disease||Sohini Anand, MBBS
|         TEMPI Syndrome||Disease||
|
|
|
|
| ||SP
|
|
|?PENDING
| ||SG
|
|
|SP (prior AE)
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee (trainee)/Fabiola Quintero-Rivera
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|
|PENDING
|
|SP
|
|
|Complete
|
|
|SG
|4/12/23 by FQR
|SP (prior AE); 2021 template added
|-
|-
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
Line 1,268: Line 1,184:
|
|
|Complete
|Complete
|5/28/2021||SG
|5/28/2021||SP
|
|
|
|SP (prior AE)
|-
|-
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|
|Complete
|Complete
|11/11/2020
|11/11/2020
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Follicular Lymphoma||Disease||Updating by Rachel Burnside; Ruthann Pfau
|Follicular Lymphoma||Disease||Ruthann Pfau
|7/28/2024
|
|
|
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE); has prior content in old template but same name in 5th edition - Rachel working on this outside of production site with new template to replace production site page later)
|-
|-
|    Testicular Follicular Lymphoma|| ||NOT NEEDED. DO NOT ASSIGN.
|    Testicular Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|
|TO BE DELETED - NOT IN 5th EDITION
|-
|-
|    In Situ Follicular Neoplasia||Disease||Rachel Burnside
|    In Situ Follicular Neoplasia||Disease||Ruthann Pfau
|7/28/2023
|
|
|
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE); 2021 template added (no prior content; name to 5th edition version of In Situ Follicular B-cell Neoplasm will be changed later but Rachel working on 5th edition content in this production site)
|-
|-
|    Duodenal-Type Follicular Lymphoma||Disease||Rachel Burnside
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|7/28/2023
|
|
|
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE); 2021 template added (name same in 5th edition version and no prior content; Rachel working on 5th edition content in this production site)
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
Line 1,322: Line 1,238:
|Complete
|Complete
|8/16/2020
|8/16/2020
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
Line 1,330: Line 1,246:
|9/30/20
|9/30/20
|Complete
|Complete
|5/26/2021||SG
|5/26/2021||SP
|
|
|
|SP (prior AE)
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|
|
|Complete
|PENDING
|09/10/2022
| ||SP
|SG
|
|
|
|SP (prior AE)
|-
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
Line 1,348: Line 1,263:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Tsigab Hagos (trainee)/Shashirekha.Shetty
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|12/19/2022
|
|1/19/2022
|
|Pending
|
|
|SP
|
|
|SG
|
|
|SP (prior AE)
|-
|-
|    In Situ Mantle Cell  Neoplasia||Disease||Rina Kansal, MD
|    In Situ Mantle Cell  Neoplasia||Disease||
|6/12/22
|
|
|
|
|SP
|
|
|Complete
|7/26/2022
|SG
|
|
|SP (prior AE); 2021 template added
|-
|-
| || ||
| || ||
Line 1,385: Line 1,300:
|Greg Corboy (GC)
|Greg Corboy (GC)
|
|
|Requested to update 14022022
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
Line 1,395: Line 1,310:
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||Laveniya Satgunaseelan
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|26/10/2021
|
|26/1/2022
|
|Complete
|
|03/28/22||GC
| ||GC
|03/28/22
|
|2021 template added
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
Line 1,451: Line 1,366:
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||Mary Haddadin
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|9/5/2023
|
|
|
|
|PENDING
| ||GC
| ||GC
|
|
|2021 template added
|
|-
|Intravascular Large B-cell Lymphoma||Disease||Kate Berry, Greg Corboy
|25/01/2022
|25/4/2022
|Complete
|9/1/22||GC
|9/1/22
|Emailed 28/3/2022 for progress update
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando (fellow), Fabiola Quintero-Rivera
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||GC
|
|
|Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note).  2021 template added. FQR emailed Manando on 4/12/23
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
Line 1,480: Line 1,395:
|Complete
|Complete
| ||GC
| ||GC
|28/03/2022
|
|
|
|-
|-
Line 1,499: Line 1,414:
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease||Sudha Arumugam
|   Multicentric Castleman  Disease||Disease||
|10/26/2021
|
|1/26/2022
|
|Complete
|24/01/2022||GC
|24/01/2022
|2021 template added
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Xiao Zhou, MD, PhD, Siparadigm
|10/26/2021
|1/26/2022
|PENDING
| ||GC
|
|
|Emailed 28/3/2022 for progress update
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||Xiao Zhou, MD, PhD, Siparadigm
|10/26/2021
|1/26/2022
|PENDING
| ||GC
| ||GC
|
|
|Emailed 28/3/2022 for progress update
|-
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|06/28/2021
|Complete
|28/06/2021||GC
|28/06/2021
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||Lauren Shealy (trainee), Daynna Wolff
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|10/13/21
|01/13/2022
|Complete
|27/01/2022
|GC
|27/01/2021
|2021 template added
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
Line 1,548: Line 1,430:
|
|
|-
|-
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||Kate Berry, Greg Corboy
|   HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||
|30/05/21
|30/08/21
|Complete
|24/02/2022||GC
|24/02/2022
|
|
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Aiko Otsubo, Holli Drendel
|7/30/21
|10/30/21
|Complete
|15/11/2021
|GC
|16/11/2021
|
|
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
| ||GC
|
|
|
|
|-
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|
|PENDING
| ||GC
| ||GC
|
|
|
|
|-
|-
| || ||
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
| ||GC
|
|
| ||Sumi Kitahara (SK)
|
|
|SP (prior AE)
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
|
|PENDING
| ||SK
|
|SP (prior AE)
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
| ||GC
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|PENDING
| ||SK
|
|SP (prior AE)
|-
|Aggressive NK-cell Leukemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD
|
|
| ||GC
|
|
|?PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||SK
| ||GC
|
|
|
|SP (prior AE)
|-
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
| || ||
|
|
|
|
|Complete
|11/21/2021||SK
|
|
|SP (prior AE)
| ||
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|PENDING
| ||SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|    Severe Mosquito Bite  Allergy||Disease||
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|PENDING
| ||SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|
|PENDING
| ||SP
|
|
|?PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
|
| ||SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|Complete
|9/26/2022
|SK
|
|
|SP (prior AE)
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
| ||SP
|
|
|Complete
|1/21/2021
|SK
|
|
|SP (prior AE)
|-
|-
|     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|  Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE)
|-
|-
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
| ||SP
|
|
|Complete
|9/26/2022
|SK
|
|
|SP (prior AE)
|-
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE)
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|
|
|Complete
|1/21/2021
|SK
|
|
|SP (prior AE)
| ||SP
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
|
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
| ||SK
|
|
|SP (prior AE)
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
| ||SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee), Tingting Barrett (trainee)
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
|
|PENDING
| ||SK
|
|SP (prior AE)
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
|
|
| ||SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|    Lymphomatoid  Papulosis||Disease||Peining Li, PhD
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SK
|
|
|SP (prior AE)
|SP
|-
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
|
|
|
|
|PENDING
|-
| ||SK
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP (prior AE)
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
|
|
|Complete
|1/21/2021
|SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|PENDING
| ||SK
|
|SP (prior AE)
|-
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
|
|
|SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SK
|
|SP (prior AE)
|-
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
|
|
|SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Bo Hong
|    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SK
|
|
|SP (prior AE); 2021 template added
|SP
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
|
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|Complete
|1/21/2021
|SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Updating by Rachel Burnside; Ruthann Pfau, Sara Akhavanfard (trainee)
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|7/28/2023
|
|
|
|
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE); (has prior content and name will change in 5th edition - Rachel working on this outside of production site to be replaced later by Nodal TFH Cell Lymphoma, Angioimmunoblastic-Type)
|-
|-
|    Follicular T-cell  Lymphoma||Disease||Rachel Burnside
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|7/28/2023
|
|
|
|PENDING
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE); 2021 template added (name to 5th edition version of Nodal TFH Cell Lymphoma, Follicular-Type will be changed later but Rachel working on 5th edition content in this production site)
|-
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SK
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara / Miguel Gonzalez (trainee)
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
|
|Completed
|09/23/2022
|SK
|
|
|SP (prior AE)
| ||SP
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara  / Miguel Gonzalez (trainee)
|
|
|
|
|Completed
|-
|09/23/2022
|    Lymphomatoid  Papulosis||Disease||
|SK
|
|
|SP (prior AE)
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE)
|-
|-
| || ||
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|
| ||
| ||SP
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Greg Corboy (GC)
| ||SP
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||Thomas Harrington (resident) + Daynna Wolff
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|06/22/2022
|09/22/2022
|PENDING
| ||GC
|
|
|2021 template added, Daynna organising
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
| ||GC
|
|
|
|
|-
|-
|    Nodular Sclerosis Classic Hodgkin Lymphoma||Disease||Xiaolin (Lynn) Hu
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
|
|Completed
|03/21/22||GC
|03/21/22
|Edits sent 14022022
|-
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
| ||SP
|
|
|PENDING
| ||GC
|
|
|2021 template added
|-
|-
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
|
|PENDING
| ||GC
|
|
|2021 template added
| ||SP
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
|
|
|PENDING
| ||GC
|
|2021 template added
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||GC
| ||SP
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|11/2/21
|02/02/22
|Completed
|03/21/22
|GC
|03/21/22
|2021 template added
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
| ||SP
|
|
|
|
|-
|-
|    Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
| ||SP
|
|
|
|
|-
|-
|    Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease||Ania Shestakova (trainee) + Fabiola Quintero-Rivera
|     Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|
|SP
|
|
|completed
|april 2022
|GC
|26/4/2022
|
|
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|    Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|          Monomorphic B-cell PTLD||Disease||
|     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease||NOT NEEDED. DO NOT ASSIGN.
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||
|SP
|
|
|
|
|-
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
| || ||
|
|
|
|
|
|
| ||GC
| ||
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease||Marie-France Gagnon, MD, Mayo Clinic (LGG fellow trainee), Xinjie Xu, PhD FACMG, Mayo Clinic
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
| ||Greg Corboy (GC)
|
|
|
|
|Complete
|10/01/2021
|GC
|10/01/2021
|Xinjie Xu
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
|
Line 2,059: Line 1,825:
|
|
|-
|-
|   Langerhans Cell  Histiocytosis||Disease||Malaika Perchard, Greg Corboy
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|02/01/2022
|
|05/01/2022
|
|Complete
|
|04/28/2022||GC
| ||GC
|5/19/2022
|
|
|-
|   Langerhans Cell  Sarcoma||Disease||Malaika Perchard, Greg Corboy
|02/01/2022
|05/01/2022
|Complete
|04/28/2022||GC
|5/19/2022
|
|
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 2,083: Line 1,841:
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 2,091: Line 1,849:
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 2,099: Line 1,857:
|
|
|-
|-
|    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|    Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 2,107: Line 1,865:
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
Line 2,115: Line 1,873:
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
|
Line 2,123: Line 1,881:
|
|
|-
|-
|Erdheim-Chester Disease||Disease||Prashant Deshpande
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|02/02/2022
|05/02/2022
|PENDING
| ||GC
|
|emailed 28/3/2022 to get update
|-
| || ||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|
|
| ||
|GC
|
|
|
|
|-
|-
| || ||
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|}<br />
==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content==
{| class="wikitable"
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
|2/20/2022
|
|
|PENDING
|
|
|Alanna Church
| ||GC
|
|
|
|
|-
|-
|Ewing Sarcoma
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|Disease
|
|Sadeem Qdaisat
|
|10/1/23
|
|
|PENDING
| ||GC
|
|
|Working with Eric McGinnis
|
|
|2021 template added
|-
|-
|}<br />
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
 
==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Astrocystoma, IDH-Mutant
|Disease
|Meenakshi Mehrotra
|6/25/2023
|
|
|PENDING
|
|
|Laveniya Satgunaseelan (LS)
|
|
|2021 template added
| ||GC
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|6/7/2022
|
|
|COMPLETE
|
|
|LS
|-
|Histiocytic Sarcoma||Disease||
|
|
|2021 template added
|-
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
|
|
|
|
|PENDING
| ||GC
|
|
|LS
|
|
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
|-
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|6/27/2023
|
|
|PENDING
|
|
|LS
|
|
|2021 template added (page created 6/27/23)
| ||GC
|-
|Angiocentric Glioma||Disease||
|
|
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
|
|-
|Diffuse Low-Grade Glioma,  MAPK Pathway-Altered||Disease||
|
|
| ||GC
|
|
|
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Diffuse Midline Glioma, H3  K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
|
|PENDING
|
|
|LS
| ||GC
|
|
|
|2021 template added
|-
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|2/21/2022
|
|
|COMPLETE
|
|
|LS
|
|
|2021 template added
| ||GC
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
|10/28/2022
|
|COMPLETE
|
|
|LS
|
|
|2021 template added
|-
|-
|Infant-Type Hemispheric Glioma||Disease||
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|
|2021 template added
|-
|-
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
|Disseminated Juvenile Xanthogranuloma||Disease||
|9/13/2022<br />
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
| ||GC
|-
|High-Grade Astrocytoma with Piloid Features||Disease||
|
|
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Pleomorphic Xanthoastrocytoma||Disease||
| || ||
|
|
|
|
|
|
| ||
|
|
|LS
|
|
|2021 template added
|-
|-
|Subependymal Giant Cell Astrocytoma||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Chordoid Glioma||Disease||
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
| || ||
|
|
|
|
|-
|Astroblastoma, MN1-Altered||Disease||
|
|
| ||
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Ganglioglioma||Disease||Leila Moayed-Aloei
| || ||
|6/30/2022
|
|
|COMPLETE
|
|
|LS
|
|
|2021 template added
| ||
|-
|Gangliocytoma||Disease||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
| || ||
|
|
|
|
|
| ||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
|-
| ||
|Dysembryoplastic Neuroepithelial Tumour||Disease||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Papillary Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Rosette-Forming Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Myxoid Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Multinodular and Vacuolating Neuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Central Neurocytoma||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Extraventricular Neurocytoma||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Cerebellar Liponeurocytoma||Disease||
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|
|}
|
|-
|Supratentorial Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Spinal Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Spinal Ependymoma, MYCN-Amplified||Disease||
|
|
|
|
|
|
|
|-
|Myxopapillary Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Subependymoma||Disease||
|
|
|
|
|
|
|
|-
|Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Atypical Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Choroid Plexus Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, Histologically Defined||Disease||
|
|
|
|
|
|
|
|-
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|
|
|
|
|
|
|
|-
|Cribriform Neuroepithelial Tumour||Disease||
|
|
|
|
|
|
|
|-
|Embryonal Tumour with Multilayered Rosettes||Disease||
|
|
|
|
|
|
|
|-
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|
|
|
|
|
|
|
|-
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|
|
|
|
|
|
|
|-
|CNS Embryonal Tumour NEC/NOS||Disease||
|
|
|
|
|
|
|
|-
|Pineocytoma||Disease||
|
|
|
|
|
|
|
|-
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|
|
|
|
|
|
|
|-
|Pineoblastoma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Tumour of the Pineal Region||Disease||
|
|
|
|
|
|
|
|-
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Schwannoma||Disease||
|
|
|
|
|
|
|
|-
|Neurofibroma||Disease||
|
|
|
|
|
|
|
|-
|Perineurioma||Disease||
|
|
|
|
|
|
|
|-
|Hybrid Nerve Sheath Tumours||Disease||
|
|
|
|
|
|
|
|-
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|
|-
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|
|-
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|
|
|
|
|
|
|
|-
|Meningioma||Disease||
|
|
|
|
|
|
|
|-
|Solitary Fibrous Tumour||Disease||
|
|
|
|
|
|
|
|-
|Haemangiomas and Vascular Malformations||Disease||
|
|
|
|
|
|
|
|-
|Haemangioblastoma||Disease||
|
|
|
|
|
|
|
|-
|Rhabdomyosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|CIC-Rearranged Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Ewing Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Mesenchymal Chondrosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Chondrosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Chordoma||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|
|
|
|
|
|
|
|-
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|
|
|
|
|
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|
|
|
|
|
|
|
|-
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|MALT Lymphoma of the Dura||Disease||
|
|
|
|
|
|
|
|-
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|MS
|
|2021 template added
|-
|T-cell and NK/T-cell Lymphomas||Disease||
|
|
|
|
|
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|
|
|-
|Rosai-Dorfman Disease||Disease||
|
|
|
|
|
|
|
|-
|Juvenile Xanthogranuloma||Disease||
|
|
|
|
|
|
|
|-
|Langerhans Cell Histiocytosis||Disease||
|
|
|
|
|
|
|
|-
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Germ Cell Tumours of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Adamantinomatous Craniopharyngioma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Craniopharyngioma||Disease||
|
|
|
|
|
|
|
|-
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|
|
|
|
|
|
|
|-
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|
|-
|Pituitary Blastoma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Meninges||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Neurofibromatosis Type 2||Disease||
|
|
|
|
|
|
|
|-
|Schwannomatosis||Disease||
|
|
|
|
|
|
|
|-
|Von Hippel-Lindau Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Tuberous Sclerosis||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
|8/22/2023
|
|PENDING
|
|LS/MS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Carney Complex||Disease||
|
|
|
|
|
|
|
|-
|DICER1 Syndrome||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Familial Paraganglioma Syndromes||Disease||
|
|
|
|
|
|
|
|-
|Melanoma-Astrocytoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Familial Retinoblastoma||Disease||
|
|
|
|
|
|
|
|-
|BAP1 Tumour Predisposition Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Fanconi Anaemia||Disease||
|
|
|
|
|
|
|
|-
|ELP1-Medulloblastoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|}<br />
==WHO Classification of Tumours of the Breast (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|Usual Ductal Hyperplasia
|Disease
|
|
|
|
|
|-
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
|
|
|
|
|
|
|
|-
|Atypical Ductal Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Sclerosing Adenosis||Disease||
|
|
|
|
|
|
|
|-
|Apocrine Adenosis and Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Microglandular Adenosis||Disease||
|
|
|
|
|
|
|
|-
|Radial Scar/Complex Sclerosing Lesion||Disease||
|
|
|
|
|
|
|
|-
|Tubular Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Lactating Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Ductal Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Pleomorphic Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|
|-
|Malignant Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|
|-
|Intraductal Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Encapsulated Papillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
|
|
|
|
|
|
|
|-
|Invasive Papillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Atypical Lobular Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Lobular Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Invasive Breast Carcinoma of No Special Type||Disease||
|
|
|
|
|
|
|
|-
|Microinvasive Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Invasive lobular Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Tubular Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Cribriform Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Mucinous Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Mucinous Cystadenocarcinoma||Disease||
|
|
|
|
|
|
|
|-
|Invasive Micropapillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Carcinoma with Apocrine Differentiation||Disease||
|
|
|
|
|
|
|
|-
|Metaplastic Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Acinic Cell Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach / Jun Liao
|10/12/02022
|11/11/2023
|COMPLETE
|
|Hui Chen / Katherine Geiersbach
|12/6/2023
|2021 template added
|-
|Secretory Carcinoma||Disease||Hui Chen / Morteza Seifi
|10/12/2022
|11/11/2023
|PENDING
|
|Katherine Geiersbach
|
|2021 template added
|-
|Mucoepidermoid Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Polymorphous Adenocarcinoma||Disease||
|
|
|
|
|
|
|
|-
|Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce
|8/11/2023
|10/11/2023
|COMPLETE
|
|Katherine Geiersbach
|
|2021 template added
|-
|Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|
|-
|Neuroendocrine Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Hamartoma||Disease||
|
|
|
|
|
|
|
|-
|Fibroadenoma||Disease||H. Evin Gulbahce / Patricija Zot
|8/11/2023
|11/11/2023
|PENDING
|
|
|
|2021 template added
|-
|Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach
|8/11/2023
|11/11/2023
|PENDING
|
|
|
|2021 template added
|-
|Syringomatous Tumour||Disease||
|
|
|
|
|
|
|
|-
|Nipple Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Paget disease of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Haemangioma||Disease||
|
|
|
|
|
|
|
|-
|Angiomatosis||Disease||
|
|
|
|
|
|
|
|-
|Atypical Vascular Lesions||Disease||
|
|
|
|
|
|
|
|-
|Postradiation Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Primary Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Nodular Fasciitis||Disease||
|
|
|
|
|
|
|
|-
|Myofibroblastoma||Disease||
|
|
|
|
|
|
|
|-
|Desmoid Fibromatosis||Disease||
|
|
|
|
|
|
|
|-
|Inflammatory Myofibroblastic Tumour||Disease||Yajuan Liu
|8/11/2023
|11/11/2023
|COMPLETE
|
|Katherine Geiersbach
|12/6/2023
|2021 template added
|-
|Schwannoma||Disease||
|
|
|
|
|
|
|
|-
|Neurofibroma||Disease||
|
|
|
|
|
|
|
|-
|Granular Cell Tumour||Disease||
|
|
|
|
|
|
|
|-
|Leiomyoma||Disease||
|
|
|
|
|
|
|
|-
|Leiomyosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Lipoma||Disease||
|
|
|
|
|
|
|
|-
|Angiolipoma||Disease||
|
|
|
|
|
|
|
|-
|Liposarcoma||Disease||
|
|
|
|
|
|
|
|-
|Pseudoangiomatous Stromal Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
|
|
|
|
|
|
|
|-
|Follicular Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Burkitt Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Gynaecomastia||Disease||
|
|
|
|
|
|
|
|-
|Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Invasive Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Breast||Disease||
|
|
|
|
|
|
|
|-
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach
|12/6/2023
|3/6/2024
|
|
|
|
|
|-
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Ataxia-Telangiectasia||Disease||Evin Gulbahce / Katherine Geiersbach
|12/11/2023
|3/11/2024
|
|
|Katherine Geiersbach
|
|
|-
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
|
|
|
|
|
|
|
|-
|CDH1-Associated Breast Cancer||Disease||
|
|
|
|
|
|
|
|-
|PALB2-Associated Cancers||Disease||Constance Albarracin / Katherine Geiersbach
|12/8/2023
|3/8/2024
|
|
|
|
|
|-
|Peutz-Jeghers Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Polygenic Component of Breast Cancer Susceptibility
|Disease
|
|
|
|
|
|
|
|
|-
|}<br />
==Genetic Tumour Syndromes (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Constitutional Mismatch Repair Deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|Named based on GTS5 book
|-
|DICER1-Related Tumour Predisposition Syndrome (DICER1)
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|Named based on GTS5 book
|-
|Neurofibromatosis Type 1 (NF1)
|Disease
|Ngoni Faya (trainee) + Madina Sukhanova
|7/12/2023
|
|PENDING
|
|Madina Sukhanova (Madina S)
|
|Named based on GTS5 book
|-
|Familial Adenomatous Polyposis (APC)
|Disease
|Jennifer Laffin
|8/20/2023
|
|PENDING
|
|MS / LS
|
|Named based on GTS5 book
|-
|}<br />
 
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
{| class="wikitable sortable"
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Gene'''
!'''Author'''
!'''Author'''
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"